SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from iBio, Inc. (IBIO) (CIK 0001420720) (IBIO) — Jul 27, 2011

iBio, Inc. (IBIO) (CIK 0001420720)
Date: July 27, 2011 · CIK: 0001420720 · Accession: 0001144204-11-042347

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-175420

Date
July 27, 2011
Author
By
Form
CORRESP
Company
iBio, Inc. (IBIO) (CIK 0001420720)

Letter

Unassociated Document

IBIO, INC.

9 Innovation Way, Suite 100

Newark, Delaware 19711

VIA EDGAR

July 27, 2011

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Jeffrey Riedler, Esq. and Scot Foley, Esq.

RE:

iBio, Inc.

Registration Statement on Form S-3 (File No. 333-175420)

Acceleration Request

Ladies and Gentlemen:

Pursuant to Rule 461, iBio, Inc. (the “Company”) hereby requests the Securities and Exchange Commission to accelerate the effective date of the above-referenced Registration Statement and declare the Registration Statement effective as of 4:00 p.m., Washington, D.C. time, on Thursday, July 28, 2011 or as soon thereafter as practicable.

The Company hereby acknowledges that:

·

should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

·

the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

·

the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Sincerely,
IBIO, INC.

Show Raw Text
CORRESP
1
filename1.htm

    Unassociated Document

IBIO, INC.

9 Innovation Way, Suite 100

Newark, Delaware 19711

VIA EDGAR

July 27, 2011

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention:  Jeffrey Riedler, Esq. and Scot Foley, Esq.

RE:

iBio, Inc.

Registration Statement on Form S-3 (File No. 333-175420)

Acceleration Request

Ladies and Gentlemen:

Pursuant to Rule 461, iBio, Inc. (the “Company”) hereby requests the Securities and Exchange Commission to accelerate the effective date of the above-referenced Registration Statement and declare the Registration Statement effective as of 4:00 p.m., Washington, D.C. time, on Thursday, July 28, 2011 or as soon thereafter as practicable.

The Company hereby acknowledges that:

·

should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

·

the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

·

the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Sincerely,

IBIO, INC.

By:

/s/ Douglas Beck

Name:

Douglas Beck

Title:

Chief Financial Officer

cc:  Robert B. Kay